CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC) 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Miles, David;  Andre, Fabrice;  Gligorov, Joseph;  Verma, Sunil;  Xu, Binghe
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 会议论文
作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Neciosup, Silvia P.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/19
Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20
作者:  O'Regan, Ruth;  Ozguroglu, Mustafa;  Andre, Fabrice;  Toi, Masakazu;  Jerusalem, Guy Heinrich Maria
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace